Avanos Medical Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.8% | -64.0% | +8.0% | +6.7% | +6.9% | +2.5% | +4.2% | -8.1% | -1.6% | +2.2% | +1.9% | |
| – | -1.9% | -74.2% | +2.1% | -4.8% | +13.0% | +9.7% | +12.5% | -20.5% | +1.3% | +4.4% | +14.9% | |
| – | -12.7% | -44.1% | +13.4% | +16.0% | +2.9% | -2.9% | -2.7% | +3.8% | -3.7% | +0.4% | -8.5% | |
| – | -3.9% | +18.9% | -0.5% | +9.4% | -9.8% | -7.4% | -7.4% | -5.3% | -11.1% | -3.7% | -11.8% | |
| – | -6.1% | +3.2% | -21.7% | +5.8% | +17.2% | -16.7% | -9.7% | +13.9% | -2.0% | -4.9% | -0.9% | |
| – | +26.8% | -2.7% | -3.7% | +0.9% | +14.5% | -21.6% | -8.3% | +20.2% | -10.7% | +8.5% | +20.3% | |
| – | -50.3% | -144.8% | – | – | -115.5% | – | +22.4% | -51.7% | +55.1% | -38.5% | -254.0% | |
| – | +451.7% | -1.2% | -3.4% | -16.5% | -43.2% | +4.0% | -78.8% | +203.0% | +50.0% | -18.7% | -67.2% | |
| – | -550.1% | – | – | – | – | – | – | +265.8% | -129.6% | – | – | |
| – | -75.4% | -453.8% | – | – | – | – | – | +420.0% | -61.5% | -950.0% | – | |
| – | -1,673.1% | – | +99.2% | -27.5% | -179.8% | – | – | +701.6% | -222.4% | – | – | |
| – | -270.9% | – | – | – | -132.7% | – | – | +59.1% | -35.0% | -783.0% | – |
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.